Authors/Disclosures
Jonathan Kleinman, MD
(BlueSky Neurology)
|
Dr. Kleinman has nothing to disclose. |
Ryan W. Snider
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
|
No disclosure on file |
Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS
(Stanford Stroke Center, Center for Academic Medicine)
|
Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell . Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKeen and associates. Dr. Venkatasubramanian has stock in Ceribell. The institution of Dr. Venkatasubramanian has received research support from Bard Inc. The institution of Dr. Venkatasubramanian has received research support from Biogen. The institution of Dr. Venkatasubramanian has received research support from NIH. |
Anna K. Finley Caulfield, MD
|
Dr. Finley Caulfield has nothing to disclose. |
Christine A. Wijman, MD
(Stanford Neurocritical Care Program, Stanford Stroke Center, SUMC)
|
No disclosure on file |